by MISG | Aug 9, 2023 | INFO
The recent Food and Drug Administration approval of the first drug shown to slow down Alzheimer’s disease means that Leqembi, whose generic name is Lecanemab, should be widely covered by the federal Medicare health insurance program. Now more people who are in...
